000
| 01100nam##2200229za#4500 |
---|
001 | 9.699606 |
---|
003 | CaOODSP |
---|
005 | 20210625000444 |
---|
007 | cr ||||||||||| |
---|
008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
---|
020 | |a978-1-100-24774-8 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-1/4-1-2014E-PDF |
---|
110 | 2 |aPublic Health Agency of Canada. |
---|
245 | 10|aSupplementary statement for recommendations related to the diagnosis, management, and follow-up of pelvic inflammatory disease : |h[electronic resource]|bCanadian guidelines on sexually transmitted infections |
---|
260 | |aOttawa - Ontario : |bPublic Health Agency of Canada |cMarch 2014. |
---|
300 | |a2p. |
---|
590 | |a14-36|b2014-09-05 |
---|
690 | 07|aSexually transmitted diseases|2gcpds |
---|
775 | 08|tDéclaration supplémentaire concernant les recommandations liées au diagnostic, à la prise en charge et au suivi des atteintes inflammatoires pelviennes : |w(CaOODSP)9.643585 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s138 KB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-1-4-1-2014-eng.pdf |
---|